“…As in Caucasians, Israel-Arab, Iraqi jews (Zhou et al, 2018), Pakistan (Jeannin et al, 2014) and India (Chakraborty & Sural, 2013), scattered hypouricemia cases have also been reported in China which displayed dispersed mutation spectrum. For example, homozygous SLC22A12: p.R90H was found in two brothers with hypouricemia (Yan, Cheng, Chen, & Lin, 2010), compound heterozygous SLC22A12: p.P78L plus p.Q382L (Lam et al, 2008), homozygous SLC2A9: p.W238X (Shen et al, 2014), homozygous splicing mutation c.1215+1 G>A in SLC2A9 (Mou, Jiang, & Hu, 2015), and compound heterozygous SLC22A12: p.R90H plus p.M430fsX466 (Zhou et al, 2018) were found in each hypouricemia patient, respectively. In another literature, three hypouricemia siblings and their normal father had heterozygous SLC22A12: p.A51fsX64 (Li et al, 2013).…”